---
authors:
- Shaughnessy, Allen
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37843954/
file_path: 2023/10/cholesterol-reducer-evolocumab-associated-with-a-nonsignific.md
issue: '4'
keywords:
- Humans
- Cardiovascular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Antibodies, Monoclonal, Humanized
- Treatment Outcome
- Anticholesteremic Agents
- Cholesterol
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents
- Cholesterol
- Cardiovascular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Treatment Outcome
original_format: PubMed
pages: 406-407
patient_population: Adults
peer_reviewed: true
pmid: '37843954'
processed_date: '2025-07-30'
publication_date: '2023-10-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-07-30'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Cholesterol-Reducer Evolocumab Associated With a Nonsignificant Increase in Cardiovascular Mortality.
topics:
- Family Medicine
volume: '108'
---

# Cholesterol-Reducer Evolocumab Associated With a Nonsignificant Increase in Cardiovascular Mortality.

**Authors:** Shaughnessy, Allen

**Published in:** American family physician | Vol. 108, No. 4 | 2023-10-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37843954/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Antibodies, Monoclonal, Humanized, Anticholesteremic Agents, Cholesterol, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Treatment Outcome

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37843954/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
